Search results
ARS Pharma (SPRY) Gets FDA Panel Vote for Epinephrine Nasal Spray
Zacks via Yahoo Finance· 1 year agoARS Pharmaceuticals’ SPRY shares rallied almost 78% on Friday. The significant increase was due to a...
Aquestive Therapeutics Reveals Favorable Data From Epinephrine Trial For Allergies
Benzinga via Yahoo Finance· 2 years agoAquestive Therapeutics Inc (NASDAQ: AQST) announced topline results from the first three arms of...
An EpiPen Alternative Could Make Treating Anaphylaxis Easier—Especially in Schools
Verywell Health via Yahoo News· 8 months agoA nasal epinephrine spray, called neffy, has been produced by ARS Pharma as an alternative to the...
Drug shortages: What to do when you can’t get your medicine
Deseret News via Yahoo News· 4 weeks agoPharmacists are seen at Jolley's Compounding Pharmacy in Salt Lake City on Tuesday, March 24, 2020....
FDA declines approval bid for Neffy, a needle-free EpiPen alternative
CBS News via Yahoo News· 9 months agoASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on...
This Asthma Drug Can Prevent Severe Food Allergies from Peanuts, Milk, and Eggs
Verywell Health via Yahoo News· 3 months agoIllustration by Julie Bang for Verywell Health Fact checked by Nick Blackmer Key Takeaways The FDA...
Aquestive's AQST-109 Compares Favorably To Widely Used EpiPen For Severe Allergic Reaction
Benzinga via Yahoo Finance· 2 years agoAquestive Therapeutics Inc (NASDAQ: AQST) announced positive topline results from the EPIPHAST 2...
Asthma drug omalizumab approved for severe food allergies
Live Science via Yahoo News· 4 months agoClose-up image of a navy-colored bowl containing salted peanuts with some unopened peanuts in their...
FDA declines approval of needle-free EpiPen alternative, wants more data
The Hill via Yahoo News· 9 months agoThe Food and Drug Administration declined to approve an epinephrine nasal spray that could have been...
Why ARS Pharmaceuticals Stock Is Soaring Today
Benzinga via Yahoo Finance· 1 year agoThe FDA's Pulmonary-Allergy Drug Advisory Committee voted 16-6 in favor of ARS Pharmaceuticals Inc's (NASDAQ: SPRY) neffy in treating severe allergic...
